Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.8162
-0.0133 (-1.60%)
Feb 11, 2026, 4:00 PM EST - Market closed
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $5.97 million as of February 11, 2026. Its market cap has decreased by -69.35% in one year.
Market Cap
5.97M
Enterprise Value
-1.10M
1-Year Change
-69.35%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $5.97M, a decrease of -97.82%. That is a compound annual growth rate of -59.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 6.07M | -29.11% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
| Nov 1, 2021 | 273.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Creative Medical Technology Holdings | 6.85M |
| Theriva Biologics | 6.70M |
| Purple Biotech | 6.63M |
| Mustang Bio | 6.33M |
| Quoin Pharmaceuticals | 6.32M |
| BioRestorative Therapies | 6.22M |
| Alaunos Therapeutics | 5.82M |
| Can-Fite BioPharma | 5.73M |